MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Cancer Treatment and Pharmacology
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,351 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,351 works in the cohort · of 4,299,418page 5 of 28

Labels cover 6 of 1,351 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,351 of 1,351 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundaboutno abstractunlabeled
Taxoids from the needles of the Canadian yew
Junzeng Zhang, Françoise Sauriol, Orval Mamer, Lolita O. Zamir
2000· article· en· Phytochemistry· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
29
citations
affunlabeled
BCIRG 005 main efficacy analysis: a phase III randomized trial comparing docetaxel in combination with doxorubicin and cyclophosphamide (TAC) versus doxorubicin and cyclophosphamide followed by docetaxel (AC→T) in women with Her-2/neu negative axillary lymph node positive early breast cancer.
W. Eiermann, Tadeusz Pieńkowski, John Crown, Linnea Chap, Marek Pawlicki, M Martin +12 more
2009· article· en· Cancer Research· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
28
citations
affno abstractunlabeled
TRIO-012: A Multicenter, Multinational, Randomized, Double-Blind Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally Recurrent or Metastatic Breast Cancer
John R. Mackey, Karen A. Gelmon, Miguel Martín, Nicole McCarthy, Tamás Pintér, Mathieu Rupin +1 more
2009· article· en· Clinical Breast Cancer· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
28
citations
affaboutunlabeled
A phase III adjuvant trial of sequenced EC + filgrastim + epoetin-alpha followed by paclitaxel compared to sequenced AC followed by paclitaxel compared to CEF in women with node-positive or high-risk node-negative breast cancer (NCIC CTG MA.21)
Margot J. Burnell, Mark N. Levine, JA Chapman, V. Bramwell, Ted Vandenberg, Haji Chalchal +4 more
2007· article· en· Journal of Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
25
citations
affaboutunlabeled
Current Canadian Experience With Capecitabine
Bonnie-Mae Gerbrecht
2003· review· en· Cancer Nursing· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
24
citations
fundno affunlabeled
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
Benedetta Pellegrino, Luigi Cavanna, Daniela Boggiani, Claudio Zamagni, Antonio Frassoldati, Alessio Schirone +16 more
2021· article· en· ESMO Open· Medicine
distilled prediction:candidate · noneconsensus · none
24
citations
affunlabeled
Capecitabine plus docetaxel combination therapy
Shailendra Verma, D Maraninchi, Joyce O’Shaughnessy, Carol Jamieson, Stephen E. Jones, Miguel Martín +4 more
2005· article· en· Cancer· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
22
citations
← previousnext →

How this was built: Screen · Findings · About